Table 1.
Baseline Demographics
| Characteristic | Entire Cohort (n = 22 680) |
|---|---|
| Years on waitlist, m(IQR) | 1.6 (0.7 – 3.1) |
| Age at delisting, m(IQR) | 57 (51 – 63) |
| Female sex, no (%) | 8805 (39) |
| Listing diagnosis, no. (%) | |
| Alcohol | 4613 (20) |
| HCV | 8762 (39) |
| NAFLD/NASH | 4840 (21) |
| Autoimmune1 | 3142 (13) |
| Other | 1323 (6) |
| Non-Hispanic white, no. (%) | 16572 (73) |
| Ascites, no. (%) | 7302 (32) |
| Hepatic encephalopathy, no. (%) | 2997 (13) |
| Diabetes Mellitus, no. (%) | 5665 (25) |
| MELDNa at listing, m(IQR) | 16 (13 – 20) |
| MELDNa at delisting, m(IQR) | 20 (14 – 29) |
| Met CKD, no. (%) | 6965 (31) |
| Hemodialysis during follow-up, no. (%) | 2522 (11) |
| Listed for SLKT, no. (%) | 2333 (10) |
| Waitlist Outcome, no. (%) | |
| Still Waiting | 8582 (38) |
| “Too Sick” or Death | 7460 (33) |
| DDLT | 6638 (29) |
1
Combined Autoimmune Hepatitis, Primary Sclerosing Cholangitis, and Primary Biliary Cholangitis; Hepatitis C (HCV); Non-Alcoholic Steatohepatitis (NASH); Model for End-Stage Liver Disease with Serum Sodium (MELDNa)